79115016 - MOLECULAR CRO

Information

• Trademark
• 79115016

• Source

• Serial Number

  79115016

• International Classifications

  • 35 - Advertising
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  February 10, 2012
  12 years ago

• Transaction Date

  September 04, 2022
  a year ago

• Status Date

  February 10, 2022
  2 years ago

• Location Date

  October 07, 2013
  10 years ago

• Status Code

  402

• Current Location

  TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  AYALA, LOURDES

• Law Office Assigned Location Code

  L60

• Owners

  • FEBIT HOLDING GMBH

Case File Statements

• GS0351: professional business consultation and business organization consultation in the market authorization of medicines and medical devices; planning and conducting of trade fairs for economic or advertising purposes; import-export agencies in the field of medicines and medical devices; wholesale store services and retail store services featuring medicines; business marketing services related to medicines and medical devices; commercial information and advice for consumers; wholesale store services in the chemical products sector; market reports and studies
• GS0441: medical services; veterinary services; hygienic and beauty care; medical diagnostic testing, monitoring and reporting services in preclinical and clinical settings; veterinary specialty services providing advanced medical and diagnostic services for animals; medical services, namely, medical and clinical examinations
• D10000: "CRO"
• GS0421: scientific and technological services, namely, scientific research, analysis and testing in the field of medicine, genetics and medical biomarkers; testing, analysis, and evaluation of medical diagnostic and biomarker preparations to assure compliance with industry standards; industrial chemical, biochemical, biological and bacteriological research and analysis; medical and scientific research information in the field of medicine, genetics and medical biomarkers; research and development of vaccines and medicines; design and testing for new product development, namely, pharmaceutical and diagnostic preparations and substances; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; testing, analyzing and evaluating new medicines; chemical research laboratories, pharmaceutical research laboratories, medical research laboratories, bacteriology research laboratories, molecular biological/biological research laboratories; medical and scientific research, namely, conducting clinical trials for others; scientific analyses in the field of chemistry, biology, molecular biology, pharmaceutics, and food technology; computer development of software in the field of the operation of therapeutic and diagnostic equipment and for the data processing for the purpose of imaging; scientific and technological services, namely, scientific research particular in the field of chemistry, genetics, biology, bioengineering, and biochemistry; chemical, biochemical, biological and bacteriological research and analysis; DNA and RNA analysis services, namely, development and research of DNA, RNA and scientific research in the field of biochemistry and biotechnology; scientific research; preparation of scientific opinions in the field of scientific research and development; advisory services relating to biotechnology, pharmaceutical research and development and genetic science; medical and scientific research, namely, the extraction or cultivation, scientific processing, and scientific analysis of biomaterials and compiling data for research purposes in the filed of medical science and medical consultancy; contract research in the field of pharmacological and clinical development of medicines; scientific data analysis for scientific and technical purposes, namely analysis of data originating from clinical trials; scientific laboratory services, namely, scientific development, research, identification, validation, analysis and interpretation of biomarkers, particularly nucleic acid based biomarkers

Case File Event Statements

• 9/4/2022 - a year ago

  28 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED Type: DENA

• 9/3/2022 - a year ago

  27 - DEATH OF INTERNATIONAL REGISTRATION Type: DETH

• 6/9/2016 - 8 years ago

  26 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 10/23/2014 - 9 years ago

  25 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINT

• 10/7/2014 - 9 years ago

  24 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 10/7/2014 - 9 years ago

  23 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 5/8/2014 - 10 years ago

  22 - CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED Type: CORN

• 4/24/2014 - 10 years ago

  21 - CORRECTION TRANSACTION RECEIVED FROM IB Type: CRCV

• 1/24/2014 - 10 years ago

  20 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 1/8/2014 - 10 years ago

  19 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 1/8/2014 - 10 years ago

  18 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 12/23/2013 - 10 years ago

  17 - CHANGE OF OWNER RECEIVED FROM IB Type: CHLD

• 10/7/2013 - 10 years ago

  16 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2

• 10/7/2013 - 10 years ago

  15 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2

• 2/22/2013 - 11 years ago

  14 - FINAL REFUSAL MAILED Type: CNFR

• 2/22/2013 - 11 years ago

  13 - FINAL REFUSAL WRITTEN Type: CNFR

• 2/7/2013 - 11 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 2/6/2013 - 11 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/6/2013 - 11 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 8/30/2012 - 11 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 8/9/2012 - 11 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 8/9/2012 - 11 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 8/9/2012 - 11 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 8/8/2012 - 11 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 8/7/2012 - 11 years ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 8/3/2012 - 11 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 8/3/2012 - 11 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 8/2/2012 - 11 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR